4.2 Article

Vasospastic Angina: An Immune-related Adverse Event

期刊

INTERNAL MEDICINE
卷 61, 期 13, 页码 1983-1986

出版社

JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.8540-21

关键词

chest pain; cancer; oncology; adverse event

向作者/读者索取更多资源

A 54-year-old Japanese woman experienced vasospastic angina after treatment with nivolumab for advanced hypopharyngeal cancer. The symptoms disappeared after discontinuing nivolumab and reappeared upon resuming the treatment. The use of benidipine provided relief from vasospastic angina.
A 54-year-old Japanese woman was admitted to our ward because of recurrent chest pain at rest for 2 months. She had been treated with nivolumab, an immune checkpoint inhibitor for inoperable advanced hypopharyngeal cancer for 21 months. She had no chest pain after cessation of nivolumab treatment. Cardiac catheterization confirmed the presence of vasospastic angina. Benidipine 8 mg was started, and she had no chest pain even after resuming therapy with nivolumab. Vasospastic angina is an adverse effect of nivolumab.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据